Cardio Diagnostics Holdings, Inc.

NCM: CDIO

Live Quote

📈 ZcoreAI Score

Our AI model analyzes Cardio Diagnostics Holdings, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.

Get CDIO Z-Score →

About Cardio Diagnostics Holdings, Inc.

Healthcare Biotechnology

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform that offers new epigenetic and genetic insights to clinicians prescribing to help improve chronic care management. It also provides CardioInnovate360, a research-use-only solution to support the discovery, development and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases; and HeartRisk, a SaaS cardiovascular disease risk intelligence platform. It serves telemedicine providers; provider organizations, such as concierge practices, longevity clinics, and risk-bearing provider organizations; and employer organizations. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.

📊 Fundamental Analysis

Cardio Diagnostics Holdings, Inc. demonstrates a profit margin of 0.0%, which is below the sector average, suggesting competitive pressure.

The company recently reported -21.2% revenue growth, which is negative, indicating a recent decline in revenue.

Return on Equity (ROE) is -78.6%, which indicates that capital utilization is currently under pressure.

At a current price of $1.83, CDIO currently trades near the bottom of its 52-week range (5%), indicating potential value or weakness (Range: $0.97 - $17.40).

🏥 Financial Health

🔴 Profit Margin Weak

✅ Debt/Equity Excellent

🔴 Revenue Growth Weak

🔴 Return on Equity Weak

🔴 Beta (Risk) High Volatility

Key Financials

Market Cap

$5.42M

Trailing P/E

Forward P/E

-7.32

Beta (5Y)

2.66

52W High

$17.40

52W Low

$0.97

Avg Volume

3.78M

Day High

Day Low

Get CDIO Z-Score on Dashboard 🚀